Fresenius (Germany) Today
| FRE Stock | EUR 32.84 0.40 1.20% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Fresenius is trading at 32.84 as of the 27th of November 2024. This is a 1.2% down since the beginning of the trading day. The stock's lowest day price was 32.84. Fresenius has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Fresenius SE Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of May 2024 and ending today, the 27th of November 2024. Click here to learn more.
KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Hhe, Germany. FRESENIUS SECO operates under Medical Care classification in Germany and is traded on Frankfurt Stock Exchange. The company has 563.24 M outstanding shares. More on Fresenius SE Co
Moving against Fresenius Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Fresenius Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Fresenius' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Fresenius or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Medical Care, Healthcare (View all Sectors) |
Fresenius SE Co (FRE) is traded on Frankfurt Exchange in Germany and employs 319,691 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 14.19 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Fresenius's market, we take the total number of its shares issued and multiply it by Fresenius's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Fresenius SE classifies itself under Healthcare sector and is part of Medical Care industry. The entity has 563.24 M outstanding shares.
Fresenius SE Co has accumulated about 1.46 B in cash with 5.08 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.63.
Check Fresenius Probability Of Bankruptcy
Ownership AllocationFresenius holds a total of 563.24 Million outstanding shares. Fresenius SE Co retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Fresenius Ownership Details
Fresenius SE Risk Profiles
Although Fresenius' alpha and beta are two of the key measurements used to evaluate Fresenius' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.9755 | |||
| Standard Deviation | 1.26 | |||
| Variance | 1.58 | |||
| Risk Adjusted Performance | 0.0028 |
Fresenius Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Fresenius without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
| All Next | Launch Module |
Fresenius Corporate Management
Elected by the shareholders, the Fresenius' board of directors comprises two types of representatives: Fresenius inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Fresenius. The board's role is to monitor Fresenius' management team and ensure that shareholders' interests are well served. Fresenius' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Fresenius' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Francesco Meo | Member SE | Profile | |
| Michael Sen | Pres CEO | Profile | |
| Sara Hennicken | Chief Officer | Profile | |
| Helen Giza | Member SE | Profile | |
| Ernst Wastler | Member SE | Profile | |
| Sebastian Biedenkopf | HR, Officer | Profile | |
| Matthias Link | Sr Communications | Profile |
Other Information on Investing in Fresenius Stock
Fresenius financial ratios help investors to determine whether Fresenius Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fresenius with respect to the benefits of owning Fresenius security.